PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
ProMIS Neurosciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.23+0.08 (+0.98%)
Close on Oct 19, 2026
- Market cap
- $75.24M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
ProMIS Neurosciences has not reported a dividend
No dividend per share appears in ProMIS Neurosciences's annual filings since fiscal 2020.